176 related articles for article (PubMed ID: 34295947)
1.
Catalan M; Dore F; Polverino P; Bertolotti C; Sartori A; Antonutti L; Cucca A; Furlanis G; Capitanio S; Manganotti P
Mov Disord Clin Pract; 2021 Jul; 8(5):717-724. PubMed ID: 34295947
[TBL] [Abstract][Full Text] [Related]
2. Optimal Protocol and Clinical Usefulness of
Chun IK
Nucl Med Mol Imaging; 2023 Jun; 57(3):145-154. PubMed ID: 37187951
[TBL] [Abstract][Full Text] [Related]
3. Combination of midbrain-to-pontine ratio and cardiac MIBG scintigraphy to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear palsy.
Sakuramoto H; Fujita H; Suzuki K; Matsubara T; Watanabe Y; Hamaguchi M; Hirata K
Clin Park Relat Disord; 2020; 2():20-24. PubMed ID: 34316615
[TBL] [Abstract][Full Text] [Related]
4. Myocardial MIBG scintigraphy in genetic Parkinson's disease as a model for Lewy body disorders.
Gabilondo I; Llorens V; Rodriguez T; Fernández M; Concha TP; Acera M; Tijero B; Murueta-Goyena A; Del Pino R; Cortés J; Gómez-Esteban JC
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):376-384. PubMed ID: 30324423
[TBL] [Abstract][Full Text] [Related]
5. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp.
Taki J; Nakajima K; Hwang EH; Matsunari I; Komai K; Yoshita M; Sakajiri K; Tonami N
Eur J Nucl Med; 2000 May; 27(5):566-73. PubMed ID: 10853813
[TBL] [Abstract][Full Text] [Related]
6. 123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis.
Orimo S; Suzuki M; Inaba A; Mizusawa H
Parkinsonism Relat Disord; 2012 Jun; 18(5):494-500. PubMed ID: 22321865
[TBL] [Abstract][Full Text] [Related]
7. MIBG myocardial scintigraphy in progressive supranuclear palsy.
Kamada T; Miura S; Kida H; Irie KI; Yamanishi Y; Hoshino T; Taniwaki T
J Neurol Sci; 2019 Jan; 396():3-7. PubMed ID: 30391822
[TBL] [Abstract][Full Text] [Related]
8.
Yang T; Wang L; Li Y; Cheng M; Jiao J; Wang Q; Guo H
J Neurol Sci; 2017 Feb; 373():48-51. PubMed ID: 28131225
[TBL] [Abstract][Full Text] [Related]
9. The Utility of the Combined Use of
Matsusue E; Fujihara Y; Tanaka K; Aozasa Y; Shimoda M; Nakayasu H; Nakamura K; Ogawa T
Yonago Acta Med; 2018 Jun; 61(2):117-127. PubMed ID: 29946218
[TBL] [Abstract][Full Text] [Related]
10. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
Yoshita M; Hayashi M; Hirai S
Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
[TBL] [Abstract][Full Text] [Related]
11. High clinical diagnostic accuracy of combined salivary gland and myocardial metaiodobenzylguanidine scintigraphy in the diagnosis of Parkinson's disease.
Li S; Yue L; Chen S; Wu Z; Zhang J; Hong R; Xie L; Peng K; Wang C; Lin A; Jin L; Guan Q
Front Aging Neurosci; 2022; 14():1066331. PubMed ID: 36711204
[TBL] [Abstract][Full Text] [Related]
12. Initial Versus Follow-up Sequential Myocardial 123I-MIBG Scintigraphy to Discriminate Parkinson Disease From Atypical Parkinsonian Syndromes.
Ryu DW; Kim JS; Lee JE; Oh YS; Yoo SW; Yoo IR; Lee KS
Clin Nucl Med; 2019 Apr; 44(4):282-288. PubMed ID: 30589669
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity and specificity of cardiac
Kawazoe M; Arima H; Maeda T; Tsuji M; Mishima T; Fujioka S; Tsugawa J; Tsuboi Y
J Neurol Sci; 2019 Dec; 407():116409. PubMed ID: 31706063
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
Fujita H; Suzuki K; Numao A; Watanabe Y; Uchiyama T; Miyamoto T; Miyamoto M; Hirata K
PLoS One; 2016; 11(11):e0165869. PubMed ID: 27812167
[TBL] [Abstract][Full Text] [Related]
15. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease.
Orimo S; Ozawa E; Nakade S; Sugimoto T; Mizusawa H
J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):189-94. PubMed ID: 10406987
[TBL] [Abstract][Full Text] [Related]
16. Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson's Disease: A Comprehensive Review.
Pitton Rissardo J; Fornari Caprara AL
Brain Sci; 2023 Oct; 13(10):. PubMed ID: 37891838
[TBL] [Abstract][Full Text] [Related]
17. SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy.
Berganzo K; Tijero B; Somme JH; Llorens V; Sánchez-Manso JC; Low D; Iodice V; Vichayanrat E; Mathias CJ; Lezcano E; Zarranz JJ; Gómez-Esteban JC
Parkinsonism Relat Disord; 2012 Jan; 18(1):45-8. PubMed ID: 21908227
[TBL] [Abstract][Full Text] [Related]
18. Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease.
Courbon F; Brefel-Courbon C; Thalamas C; Alibelli MJ; Berry I; Montastruc JL; Rascol O; Senard JM
Mov Disord; 2003 Aug; 18(8):890-7. PubMed ID: 12889078
[TBL] [Abstract][Full Text] [Related]
19. 123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders.
Nuvoli S; Spanu A; Piras MR; Nieddu A; Mulas A; Rocchitta G; Galleri G; Serra PA; Madeddu G
Medicine (Baltimore); 2017 May; 96(21):e6967. PubMed ID: 28538394
[TBL] [Abstract][Full Text] [Related]
20. Cardiac 123I-MIBG Scintigraphy in Neurodegenerative Parkinson Syndromes: Performance and Pitfalls in Clinical Practice.
Skowronek C; Zange L; Lipp A
Front Neurol; 2019; 10():152. PubMed ID: 30863360
[No Abstract] [Full Text] [Related]
[Next] [New Search]
